|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.51 CAD | 0.00% |
|
+0.12% | -7.70% |
| Apr. 22 | BioSyent Inc.(TSXV:RX) dropped from S&P/TSX Venture Composite Index | CI |
| Apr. 01 | BioSyent To Present At LD Micro New York Investor Conference | MT |
BioSyent Inc. (TSXV:RX) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 650,000 shares, representing 5.53% of its outstanding shares. The bid will terminate on December 18, 2024, or such earlier date on which purchases under the bid have been completed.
As of December 13, 2023, the company had 11,761,166 common shares outstanding.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.70% | 72.15M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
BIOSYENT INC. 
